Vera Bradley, Inc. Names Jacqueline Ardrey New President And Chief Executive Officer
Ardrey will join the Company on November 1, 2022
Ardrey will replace Rob Wallstrom, who will remain with the Company through December 2022, to serve as an advisor to Ardrey and ensure a smooth transition
Related news for (VRA)
- Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- 24/7 Market News Snapshot 06 October, 2025 – Zevra Therapeutics, Inc. Common Stock (NASDAQ:ZVRA)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/26/25 08:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/26/25 07:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/20/25 07:00 PM
